Frontiers in Genetics-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2179183, encodeId=9b4221e9183e1, content=审稿速度:2.0 经验分享：经验分享：11月03日投稿，11月06日审稿人1 建议拒稿，11月27日审稿人2 建议Minor revision，11月28日审稿人3建议Major revision，给了2周返修时间，12月10日所有意见返修过去， 12月27日审稿人3 建议拒稿，12月28日，审稿人2 同意发表。各位帮忙分析一下我的文章还有戏吗? 焦虑中......., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=253, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=80c66157856, createdName=ms3000000029380120, createdTime=Thu Jan 04 10:11:21 CST 2024, time=2024-01-04, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1192128, encodeId=6ea2119212886, content=我的intial validation20天了。。。有没有大哥跟这个情况一样, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=22, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2fbe5639152, createdName=ms8000000759319128, createdTime=Fri Feb 11 00:09:31 CST 2022, time=2022-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2120586, encodeId=14f8212058655, content=偏重的研究方向：基因 经验分享：initial validation 3天了，一般多久啊😂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a9a48344813, createdName=ms3000001292138274, createdTime=Mon Mar 20 15:51:11 CST 2023, time=2023-03-20, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2227090, encodeId=5827222e090d9, content=我是这个杂志社的审稿人，我只要是临床工作不忙，一般都是2-3天内审完提交。因为自己经常经历漫长的投稿时间。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=283, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0ea8286723, createdName=ms3000000851999119, createdTime=Sun Sep 22 18:38:56 CST 2024, time=2024-09-22, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2221839, encodeId=9194222183913, content=偏重的研究方向：肿瘤;基因 经验分享：6月27submit 8月3日第一轮审稿意见回来，一共2个审稿人 8月14日修回 8月15日一个审稿人再次提出了一些建议，当天就修回了 8月16日和8月17日2个审稿人陆续endorse 8月21日接收整个过程挺顺利的，审稿人的审稿意见都很中肯。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a0558563830, createdName=ms1000001357370242, createdTime=Thu Aug 22 08:43:43 CST 2024, time=2024-08-22, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2216376, encodeId=039a22163e6e5, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：植物转录组 经验分享：请问大家投Frontier in genetics之前都查重了吗？杂志对重复率的要求是怎么样的呀？请前辈们都来指点迷津, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=192, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5a459395780, createdName=ms2000001592249343, createdTime=Tue Jul 23 09:02:04 CST 2024, time=2024-07-23, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=1222701, encodeId=fc861222e0150, content=偏重的研究方向：生物信息 经验分享：4.16刚投了一个偏重算法的纯生信，副主编一共就请了2个审稿人，审稿人1非常nice直接同意接收，审稿人2的问题比较刁钻，尽力回复了也给拒了。副主编还会请第三位审稿人吗😔😔😔, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=233, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220527/f872d11666ad4271be846f74e02b89b7/5532cc15e85e4719abf96a130465c946.jpg, createdBy=2c908142929, createdName=ms1000001205788873, createdTime=Fri May 27 00:11:16 CST 2022, time=2022-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2116489, encodeId=b5f72116489b1, content=偏重的研究方向：肿瘤;纯生信;基因 经验分享：投了一篇转录因子调控网络图的纯生信，第一个审稿人给了2323，主要要求要我补实验，别的都是统计学小问题，准备补个PCR，希望可以过！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab055420094, createdName=少年宁, createdTime=Sun Feb 26 00:25:27 CST 2023, time=2023-02-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2203484, encodeId=0d482203484f1, content=This manuscript does not fulfill the standards established for the journal to be considered for publication, and according to Frontiers policies (https://www***ontiersin.org/guidelines/policies-and-publication-ethics#AuthorshipAuthorResponsibilities), the article is being rejected. This decision applies across all Frontiers journals and is final., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8fe96448100, createdName=ms3000000420360328, createdTime=Wed May 08 17:28:10 CST 2024, time=2024-05-08, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2145809, encodeId=544b214580929, content=审稿速度:6.0 经验分享：太无耻了，开始找的第一个审稿人建议大修，返回已经后是同意录用，后面一直在找别的审稿人，到投稿6个月的时候才找到第二个审稿人。但是奇葩操作来了，在最后一个审稿人没回复的情况下，编辑直接拒稿，我是想问这个杂志社是不是有毛病？拒稿为什么不早点拒稿，耽误别人半年时间，我想请问能不能发邮件喷这个SB编辑，再也不投这个fronter系列杂志了，白白延误别人时间又莫名其妙的拒稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=024e2688919, createdName=287119938, createdTime=Sat Jul 01 12:35:51 CST 2023, time=2023-07-01, status=1, ipAttribution=贵州省)]

2024-01-04 ms3000000029380120 来自江苏省

审稿速度:2.0
经验分享：经验分享：11月03日投稿，11月06日审稿人1 建议拒稿，11月27日审稿人2 建议Minor revision，11月28日审稿人3建议Major revision，给了2周返修时间，12月10日所有意见返修过去， 12月27日审稿人3 建议拒稿，12月28日，审稿人2 同意发表。各位帮忙分析一下我的文章还有戏吗? 焦虑中.......

253 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2179183, encodeId=9b4221e9183e1, content=审稿速度:2.0 经验分享：经验分享：11月03日投稿，11月06日审稿人1 建议拒稿，11月27日审稿人2 建议Minor revision，11月28日审稿人3建议Major revision，给了2周返修时间，12月10日所有意见返修过去， 12月27日审稿人3 建议拒稿，12月28日，审稿人2 同意发表。各位帮忙分析一下我的文章还有戏吗? 焦虑中......., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=253, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=80c66157856, createdName=ms3000000029380120, createdTime=Thu Jan 04 10:11:21 CST 2024, time=2024-01-04, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1192128, encodeId=6ea2119212886, content=我的intial validation20天了。。。有没有大哥跟这个情况一样, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=22, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2fbe5639152, createdName=ms8000000759319128, createdTime=Fri Feb 11 00:09:31 CST 2022, time=2022-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2120586, encodeId=14f8212058655, content=偏重的研究方向：基因 经验分享：initial validation 3天了，一般多久啊😂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a9a48344813, createdName=ms3000001292138274, createdTime=Mon Mar 20 15:51:11 CST 2023, time=2023-03-20, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2227090, encodeId=5827222e090d9, content=我是这个杂志社的审稿人，我只要是临床工作不忙，一般都是2-3天内审完提交。因为自己经常经历漫长的投稿时间。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=283, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0ea8286723, createdName=ms3000000851999119, createdTime=Sun Sep 22 18:38:56 CST 2024, time=2024-09-22, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2221839, encodeId=9194222183913, content=偏重的研究方向：肿瘤;基因 经验分享：6月27submit 8月3日第一轮审稿意见回来，一共2个审稿人 8月14日修回 8月15日一个审稿人再次提出了一些建议，当天就修回了 8月16日和8月17日2个审稿人陆续endorse 8月21日接收整个过程挺顺利的，审稿人的审稿意见都很中肯。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a0558563830, createdName=ms1000001357370242, createdTime=Thu Aug 22 08:43:43 CST 2024, time=2024-08-22, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2216376, encodeId=039a22163e6e5, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：植物转录组 经验分享：请问大家投Frontier in genetics之前都查重了吗？杂志对重复率的要求是怎么样的呀？请前辈们都来指点迷津, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=192, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5a459395780, createdName=ms2000001592249343, createdTime=Tue Jul 23 09:02:04 CST 2024, time=2024-07-23, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=1222701, encodeId=fc861222e0150, content=偏重的研究方向：生物信息 经验分享：4.16刚投了一个偏重算法的纯生信，副主编一共就请了2个审稿人，审稿人1非常nice直接同意接收，审稿人2的问题比较刁钻，尽力回复了也给拒了。副主编还会请第三位审稿人吗😔😔😔, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=233, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220527/f872d11666ad4271be846f74e02b89b7/5532cc15e85e4719abf96a130465c946.jpg, createdBy=2c908142929, createdName=ms1000001205788873, createdTime=Fri May 27 00:11:16 CST 2022, time=2022-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2116489, encodeId=b5f72116489b1, content=偏重的研究方向：肿瘤;纯生信;基因 经验分享：投了一篇转录因子调控网络图的纯生信，第一个审稿人给了2323，主要要求要我补实验，别的都是统计学小问题，准备补个PCR，希望可以过！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab055420094, createdName=少年宁, createdTime=Sun Feb 26 00:25:27 CST 2023, time=2023-02-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2203484, encodeId=0d482203484f1, content=This manuscript does not fulfill the standards established for the journal to be considered for publication, and according to Frontiers policies (https://www***ontiersin.org/guidelines/policies-and-publication-ethics#AuthorshipAuthorResponsibilities), the article is being rejected. This decision applies across all Frontiers journals and is final., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8fe96448100, createdName=ms3000000420360328, createdTime=Wed May 08 17:28:10 CST 2024, time=2024-05-08, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2145809, encodeId=544b214580929, content=审稿速度:6.0 经验分享：太无耻了，开始找的第一个审稿人建议大修，返回已经后是同意录用，后面一直在找别的审稿人，到投稿6个月的时候才找到第二个审稿人。但是奇葩操作来了，在最后一个审稿人没回复的情况下，编辑直接拒稿，我是想问这个杂志社是不是有毛病？拒稿为什么不早点拒稿，耽误别人半年时间，我想请问能不能发邮件喷这个SB编辑，再也不投这个fronter系列杂志了，白白延误别人时间又莫名其妙的拒稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=024e2688919, createdName=287119938, createdTime=Sat Jul 01 12:35:51 CST 2023, time=2023-07-01, status=1, ipAttribution=贵州省)]

2022-02-11 ms8000000759319128

我的intial validation20天了。。。有没有大哥跟这个情况一样

125 22

展开22条回复

[GetPortalCommentsPageByObjectIdResponse(id=2179183, encodeId=9b4221e9183e1, content=审稿速度:2.0 经验分享：经验分享：11月03日投稿，11月06日审稿人1 建议拒稿，11月27日审稿人2 建议Minor revision，11月28日审稿人3建议Major revision，给了2周返修时间，12月10日所有意见返修过去， 12月27日审稿人3 建议拒稿，12月28日，审稿人2 同意发表。各位帮忙分析一下我的文章还有戏吗? 焦虑中......., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=253, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=80c66157856, createdName=ms3000000029380120, createdTime=Thu Jan 04 10:11:21 CST 2024, time=2024-01-04, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1192128, encodeId=6ea2119212886, content=我的intial validation20天了。。。有没有大哥跟这个情况一样, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=22, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2fbe5639152, createdName=ms8000000759319128, createdTime=Fri Feb 11 00:09:31 CST 2022, time=2022-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2120586, encodeId=14f8212058655, content=偏重的研究方向：基因 经验分享：initial validation 3天了，一般多久啊😂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a9a48344813, createdName=ms3000001292138274, createdTime=Mon Mar 20 15:51:11 CST 2023, time=2023-03-20, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2227090, encodeId=5827222e090d9, content=我是这个杂志社的审稿人，我只要是临床工作不忙，一般都是2-3天内审完提交。因为自己经常经历漫长的投稿时间。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=283, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0ea8286723, createdName=ms3000000851999119, createdTime=Sun Sep 22 18:38:56 CST 2024, time=2024-09-22, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2221839, encodeId=9194222183913, content=偏重的研究方向：肿瘤;基因 经验分享：6月27submit 8月3日第一轮审稿意见回来，一共2个审稿人 8月14日修回 8月15日一个审稿人再次提出了一些建议，当天就修回了 8月16日和8月17日2个审稿人陆续endorse 8月21日接收整个过程挺顺利的，审稿人的审稿意见都很中肯。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a0558563830, createdName=ms1000001357370242, createdTime=Thu Aug 22 08:43:43 CST 2024, time=2024-08-22, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2216376, encodeId=039a22163e6e5, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：植物转录组 经验分享：请问大家投Frontier in genetics之前都查重了吗？杂志对重复率的要求是怎么样的呀？请前辈们都来指点迷津, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=192, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5a459395780, createdName=ms2000001592249343, createdTime=Tue Jul 23 09:02:04 CST 2024, time=2024-07-23, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=1222701, encodeId=fc861222e0150, content=偏重的研究方向：生物信息 经验分享：4.16刚投了一个偏重算法的纯生信，副主编一共就请了2个审稿人，审稿人1非常nice直接同意接收，审稿人2的问题比较刁钻，尽力回复了也给拒了。副主编还会请第三位审稿人吗😔😔😔, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=233, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220527/f872d11666ad4271be846f74e02b89b7/5532cc15e85e4719abf96a130465c946.jpg, createdBy=2c908142929, createdName=ms1000001205788873, createdTime=Fri May 27 00:11:16 CST 2022, time=2022-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2116489, encodeId=b5f72116489b1, content=偏重的研究方向：肿瘤;纯生信;基因 经验分享：投了一篇转录因子调控网络图的纯生信，第一个审稿人给了2323，主要要求要我补实验，别的都是统计学小问题，准备补个PCR，希望可以过！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab055420094, createdName=少年宁, createdTime=Sun Feb 26 00:25:27 CST 2023, time=2023-02-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2203484, encodeId=0d482203484f1, content=This manuscript does not fulfill the standards established for the journal to be considered for publication, and according to Frontiers policies (https://www***ontiersin.org/guidelines/policies-and-publication-ethics#AuthorshipAuthorResponsibilities), the article is being rejected. This decision applies across all Frontiers journals and is final., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8fe96448100, createdName=ms3000000420360328, createdTime=Wed May 08 17:28:10 CST 2024, time=2024-05-08, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2145809, encodeId=544b214580929, content=审稿速度:6.0 经验分享：太无耻了，开始找的第一个审稿人建议大修，返回已经后是同意录用，后面一直在找别的审稿人，到投稿6个月的时候才找到第二个审稿人。但是奇葩操作来了，在最后一个审稿人没回复的情况下，编辑直接拒稿，我是想问这个杂志社是不是有毛病？拒稿为什么不早点拒稿，耽误别人半年时间，我想请问能不能发邮件喷这个SB编辑，再也不投这个fronter系列杂志了，白白延误别人时间又莫名其妙的拒稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=024e2688919, createdName=287119938, createdTime=Sat Jul 01 12:35:51 CST 2023, time=2023-07-01, status=1, ipAttribution=贵州省)]

2023-03-20 ms3000001292138274 来自广东省

偏重的研究方向：基因
经验分享：initial validation 3天了，一般多久啊😂

96 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2179183, encodeId=9b4221e9183e1, content=审稿速度:2.0 经验分享：经验分享：11月03日投稿，11月06日审稿人1 建议拒稿，11月27日审稿人2 建议Minor revision，11月28日审稿人3建议Major revision，给了2周返修时间，12月10日所有意见返修过去， 12月27日审稿人3 建议拒稿，12月28日，审稿人2 同意发表。各位帮忙分析一下我的文章还有戏吗? 焦虑中......., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=253, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=80c66157856, createdName=ms3000000029380120, createdTime=Thu Jan 04 10:11:21 CST 2024, time=2024-01-04, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1192128, encodeId=6ea2119212886, content=我的intial validation20天了。。。有没有大哥跟这个情况一样, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=22, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2fbe5639152, createdName=ms8000000759319128, createdTime=Fri Feb 11 00:09:31 CST 2022, time=2022-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2120586, encodeId=14f8212058655, content=偏重的研究方向：基因 经验分享：initial validation 3天了，一般多久啊😂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a9a48344813, createdName=ms3000001292138274, createdTime=Mon Mar 20 15:51:11 CST 2023, time=2023-03-20, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2227090, encodeId=5827222e090d9, content=我是这个杂志社的审稿人，我只要是临床工作不忙，一般都是2-3天内审完提交。因为自己经常经历漫长的投稿时间。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=283, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0ea8286723, createdName=ms3000000851999119, createdTime=Sun Sep 22 18:38:56 CST 2024, time=2024-09-22, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2221839, encodeId=9194222183913, content=偏重的研究方向：肿瘤;基因 经验分享：6月27submit 8月3日第一轮审稿意见回来，一共2个审稿人 8月14日修回 8月15日一个审稿人再次提出了一些建议，当天就修回了 8月16日和8月17日2个审稿人陆续endorse 8月21日接收整个过程挺顺利的，审稿人的审稿意见都很中肯。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a0558563830, createdName=ms1000001357370242, createdTime=Thu Aug 22 08:43:43 CST 2024, time=2024-08-22, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2216376, encodeId=039a22163e6e5, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：植物转录组 经验分享：请问大家投Frontier in genetics之前都查重了吗？杂志对重复率的要求是怎么样的呀？请前辈们都来指点迷津, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=192, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5a459395780, createdName=ms2000001592249343, createdTime=Tue Jul 23 09:02:04 CST 2024, time=2024-07-23, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=1222701, encodeId=fc861222e0150, content=偏重的研究方向：生物信息 经验分享：4.16刚投了一个偏重算法的纯生信，副主编一共就请了2个审稿人，审稿人1非常nice直接同意接收，审稿人2的问题比较刁钻，尽力回复了也给拒了。副主编还会请第三位审稿人吗😔😔😔, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=233, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220527/f872d11666ad4271be846f74e02b89b7/5532cc15e85e4719abf96a130465c946.jpg, createdBy=2c908142929, createdName=ms1000001205788873, createdTime=Fri May 27 00:11:16 CST 2022, time=2022-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2116489, encodeId=b5f72116489b1, content=偏重的研究方向：肿瘤;纯生信;基因 经验分享：投了一篇转录因子调控网络图的纯生信，第一个审稿人给了2323，主要要求要我补实验，别的都是统计学小问题，准备补个PCR，希望可以过！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab055420094, createdName=少年宁, createdTime=Sun Feb 26 00:25:27 CST 2023, time=2023-02-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2203484, encodeId=0d482203484f1, content=This manuscript does not fulfill the standards established for the journal to be considered for publication, and according to Frontiers policies (https://www***ontiersin.org/guidelines/policies-and-publication-ethics#AuthorshipAuthorResponsibilities), the article is being rejected. This decision applies across all Frontiers journals and is final., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8fe96448100, createdName=ms3000000420360328, createdTime=Wed May 08 17:28:10 CST 2024, time=2024-05-08, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2145809, encodeId=544b214580929, content=审稿速度:6.0 经验分享：太无耻了，开始找的第一个审稿人建议大修，返回已经后是同意录用，后面一直在找别的审稿人，到投稿6个月的时候才找到第二个审稿人。但是奇葩操作来了，在最后一个审稿人没回复的情况下，编辑直接拒稿，我是想问这个杂志社是不是有毛病？拒稿为什么不早点拒稿，耽误别人半年时间，我想请问能不能发邮件喷这个SB编辑，再也不投这个fronter系列杂志了，白白延误别人时间又莫名其妙的拒稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=024e2688919, createdName=287119938, createdTime=Sat Jul 01 12:35:51 CST 2023, time=2023-07-01, status=1, ipAttribution=贵州省)]

2024-09-22 ms3000000851999119 来自北京

我是这个杂志社的审稿人，我只要是临床工作不忙，一般都是2-3天内审完提交。因为自己经常经历漫长的投稿时间。

283 5

展开5条回复

[GetPortalCommentsPageByObjectIdResponse(id=2179183, encodeId=9b4221e9183e1, content=审稿速度:2.0 经验分享：经验分享：11月03日投稿，11月06日审稿人1 建议拒稿，11月27日审稿人2 建议Minor revision，11月28日审稿人3建议Major revision，给了2周返修时间，12月10日所有意见返修过去， 12月27日审稿人3 建议拒稿，12月28日，审稿人2 同意发表。各位帮忙分析一下我的文章还有戏吗? 焦虑中......., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=253, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=80c66157856, createdName=ms3000000029380120, createdTime=Thu Jan 04 10:11:21 CST 2024, time=2024-01-04, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1192128, encodeId=6ea2119212886, content=我的intial validation20天了。。。有没有大哥跟这个情况一样, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=22, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2fbe5639152, createdName=ms8000000759319128, createdTime=Fri Feb 11 00:09:31 CST 2022, time=2022-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2120586, encodeId=14f8212058655, content=偏重的研究方向：基因 经验分享：initial validation 3天了，一般多久啊😂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a9a48344813, createdName=ms3000001292138274, createdTime=Mon Mar 20 15:51:11 CST 2023, time=2023-03-20, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2227090, encodeId=5827222e090d9, content=我是这个杂志社的审稿人，我只要是临床工作不忙，一般都是2-3天内审完提交。因为自己经常经历漫长的投稿时间。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=283, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0ea8286723, createdName=ms3000000851999119, createdTime=Sun Sep 22 18:38:56 CST 2024, time=2024-09-22, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2221839, encodeId=9194222183913, content=偏重的研究方向：肿瘤;基因 经验分享：6月27submit 8月3日第一轮审稿意见回来，一共2个审稿人 8月14日修回 8月15日一个审稿人再次提出了一些建议，当天就修回了 8月16日和8月17日2个审稿人陆续endorse 8月21日接收整个过程挺顺利的，审稿人的审稿意见都很中肯。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a0558563830, createdName=ms1000001357370242, createdTime=Thu Aug 22 08:43:43 CST 2024, time=2024-08-22, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2216376, encodeId=039a22163e6e5, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：植物转录组 经验分享：请问大家投Frontier in genetics之前都查重了吗？杂志对重复率的要求是怎么样的呀？请前辈们都来指点迷津, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=192, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5a459395780, createdName=ms2000001592249343, createdTime=Tue Jul 23 09:02:04 CST 2024, time=2024-07-23, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=1222701, encodeId=fc861222e0150, content=偏重的研究方向：生物信息 经验分享：4.16刚投了一个偏重算法的纯生信，副主编一共就请了2个审稿人，审稿人1非常nice直接同意接收，审稿人2的问题比较刁钻，尽力回复了也给拒了。副主编还会请第三位审稿人吗😔😔😔, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=233, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220527/f872d11666ad4271be846f74e02b89b7/5532cc15e85e4719abf96a130465c946.jpg, createdBy=2c908142929, createdName=ms1000001205788873, createdTime=Fri May 27 00:11:16 CST 2022, time=2022-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2116489, encodeId=b5f72116489b1, content=偏重的研究方向：肿瘤;纯生信;基因 经验分享：投了一篇转录因子调控网络图的纯生信，第一个审稿人给了2323，主要要求要我补实验，别的都是统计学小问题，准备补个PCR，希望可以过！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab055420094, createdName=少年宁, createdTime=Sun Feb 26 00:25:27 CST 2023, time=2023-02-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2203484, encodeId=0d482203484f1, content=This manuscript does not fulfill the standards established for the journal to be considered for publication, and according to Frontiers policies (https://www***ontiersin.org/guidelines/policies-and-publication-ethics#AuthorshipAuthorResponsibilities), the article is being rejected. This decision applies across all Frontiers journals and is final., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8fe96448100, createdName=ms3000000420360328, createdTime=Wed May 08 17:28:10 CST 2024, time=2024-05-08, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2145809, encodeId=544b214580929, content=审稿速度:6.0 经验分享：太无耻了，开始找的第一个审稿人建议大修，返回已经后是同意录用，后面一直在找别的审稿人，到投稿6个月的时候才找到第二个审稿人。但是奇葩操作来了，在最后一个审稿人没回复的情况下，编辑直接拒稿，我是想问这个杂志社是不是有毛病？拒稿为什么不早点拒稿，耽误别人半年时间，我想请问能不能发邮件喷这个SB编辑，再也不投这个fronter系列杂志了，白白延误别人时间又莫名其妙的拒稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=024e2688919, createdName=287119938, createdTime=Sat Jul 01 12:35:51 CST 2023, time=2023-07-01, status=1, ipAttribution=贵州省)]

2024-08-22 ms1000001357370242 来自广东省

偏重的研究方向：肿瘤;基因
经验分享：6月27submit 8月3日第一轮审稿意见回来，一共2个审稿人 8月14日修回 8月15日一个审稿人再次提出了一些建议，当天就修回了 8月16日和8月17日2个审稿人陆续endorse 8月21日接收整个过程挺顺利的，审稿人的审稿意见都很中肯。

0 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2179183, encodeId=9b4221e9183e1, content=审稿速度:2.0 经验分享：经验分享：11月03日投稿，11月06日审稿人1 建议拒稿，11月27日审稿人2 建议Minor revision，11月28日审稿人3建议Major revision，给了2周返修时间，12月10日所有意见返修过去， 12月27日审稿人3 建议拒稿，12月28日，审稿人2 同意发表。各位帮忙分析一下我的文章还有戏吗? 焦虑中......., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=253, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=80c66157856, createdName=ms3000000029380120, createdTime=Thu Jan 04 10:11:21 CST 2024, time=2024-01-04, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1192128, encodeId=6ea2119212886, content=我的intial validation20天了。。。有没有大哥跟这个情况一样, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=22, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2fbe5639152, createdName=ms8000000759319128, createdTime=Fri Feb 11 00:09:31 CST 2022, time=2022-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2120586, encodeId=14f8212058655, content=偏重的研究方向：基因 经验分享：initial validation 3天了，一般多久啊😂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a9a48344813, createdName=ms3000001292138274, createdTime=Mon Mar 20 15:51:11 CST 2023, time=2023-03-20, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2227090, encodeId=5827222e090d9, content=我是这个杂志社的审稿人，我只要是临床工作不忙，一般都是2-3天内审完提交。因为自己经常经历漫长的投稿时间。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=283, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0ea8286723, createdName=ms3000000851999119, createdTime=Sun Sep 22 18:38:56 CST 2024, time=2024-09-22, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2221839, encodeId=9194222183913, content=偏重的研究方向：肿瘤;基因 经验分享：6月27submit 8月3日第一轮审稿意见回来，一共2个审稿人 8月14日修回 8月15日一个审稿人再次提出了一些建议，当天就修回了 8月16日和8月17日2个审稿人陆续endorse 8月21日接收整个过程挺顺利的，审稿人的审稿意见都很中肯。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a0558563830, createdName=ms1000001357370242, createdTime=Thu Aug 22 08:43:43 CST 2024, time=2024-08-22, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2216376, encodeId=039a22163e6e5, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：植物转录组 经验分享：请问大家投Frontier in genetics之前都查重了吗？杂志对重复率的要求是怎么样的呀？请前辈们都来指点迷津, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=192, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5a459395780, createdName=ms2000001592249343, createdTime=Tue Jul 23 09:02:04 CST 2024, time=2024-07-23, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=1222701, encodeId=fc861222e0150, content=偏重的研究方向：生物信息 经验分享：4.16刚投了一个偏重算法的纯生信，副主编一共就请了2个审稿人，审稿人1非常nice直接同意接收，审稿人2的问题比较刁钻，尽力回复了也给拒了。副主编还会请第三位审稿人吗😔😔😔, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=233, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220527/f872d11666ad4271be846f74e02b89b7/5532cc15e85e4719abf96a130465c946.jpg, createdBy=2c908142929, createdName=ms1000001205788873, createdTime=Fri May 27 00:11:16 CST 2022, time=2022-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2116489, encodeId=b5f72116489b1, content=偏重的研究方向：肿瘤;纯生信;基因 经验分享：投了一篇转录因子调控网络图的纯生信，第一个审稿人给了2323，主要要求要我补实验，别的都是统计学小问题，准备补个PCR，希望可以过！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab055420094, createdName=少年宁, createdTime=Sun Feb 26 00:25:27 CST 2023, time=2023-02-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2203484, encodeId=0d482203484f1, content=This manuscript does not fulfill the standards established for the journal to be considered for publication, and according to Frontiers policies (https://www***ontiersin.org/guidelines/policies-and-publication-ethics#AuthorshipAuthorResponsibilities), the article is being rejected. This decision applies across all Frontiers journals and is final., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8fe96448100, createdName=ms3000000420360328, createdTime=Wed May 08 17:28:10 CST 2024, time=2024-05-08, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2145809, encodeId=544b214580929, content=审稿速度:6.0 经验分享：太无耻了，开始找的第一个审稿人建议大修，返回已经后是同意录用，后面一直在找别的审稿人，到投稿6个月的时候才找到第二个审稿人。但是奇葩操作来了，在最后一个审稿人没回复的情况下，编辑直接拒稿，我是想问这个杂志社是不是有毛病？拒稿为什么不早点拒稿，耽误别人半年时间，我想请问能不能发邮件喷这个SB编辑，再也不投这个fronter系列杂志了，白白延误别人时间又莫名其妙的拒稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=024e2688919, createdName=287119938, createdTime=Sat Jul 01 12:35:51 CST 2023, time=2023-07-01, status=1, ipAttribution=贵州省)]

2024-07-23 ms2000001592249343 来自甘肃省

审稿速度:3.0 | 投稿命中率:50.0
偏重的研究方向：植物转录组
经验分享：请问大家投Frontier in genetics之前都查重了吗？杂志对重复率的要求是怎么样的呀？请前辈们都来指点迷津

192 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2179183, encodeId=9b4221e9183e1, content=审稿速度:2.0 经验分享：经验分享：11月03日投稿，11月06日审稿人1 建议拒稿，11月27日审稿人2 建议Minor revision，11月28日审稿人3建议Major revision，给了2周返修时间，12月10日所有意见返修过去， 12月27日审稿人3 建议拒稿，12月28日，审稿人2 同意发表。各位帮忙分析一下我的文章还有戏吗? 焦虑中......., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=253, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=80c66157856, createdName=ms3000000029380120, createdTime=Thu Jan 04 10:11:21 CST 2024, time=2024-01-04, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1192128, encodeId=6ea2119212886, content=我的intial validation20天了。。。有没有大哥跟这个情况一样, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=22, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2fbe5639152, createdName=ms8000000759319128, createdTime=Fri Feb 11 00:09:31 CST 2022, time=2022-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2120586, encodeId=14f8212058655, content=偏重的研究方向：基因 经验分享：initial validation 3天了，一般多久啊😂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a9a48344813, createdName=ms3000001292138274, createdTime=Mon Mar 20 15:51:11 CST 2023, time=2023-03-20, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2227090, encodeId=5827222e090d9, content=我是这个杂志社的审稿人，我只要是临床工作不忙，一般都是2-3天内审完提交。因为自己经常经历漫长的投稿时间。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=283, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0ea8286723, createdName=ms3000000851999119, createdTime=Sun Sep 22 18:38:56 CST 2024, time=2024-09-22, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2221839, encodeId=9194222183913, content=偏重的研究方向：肿瘤;基因 经验分享：6月27submit 8月3日第一轮审稿意见回来，一共2个审稿人 8月14日修回 8月15日一个审稿人再次提出了一些建议，当天就修回了 8月16日和8月17日2个审稿人陆续endorse 8月21日接收整个过程挺顺利的，审稿人的审稿意见都很中肯。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a0558563830, createdName=ms1000001357370242, createdTime=Thu Aug 22 08:43:43 CST 2024, time=2024-08-22, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2216376, encodeId=039a22163e6e5, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：植物转录组 经验分享：请问大家投Frontier in genetics之前都查重了吗？杂志对重复率的要求是怎么样的呀？请前辈们都来指点迷津, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=192, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5a459395780, createdName=ms2000001592249343, createdTime=Tue Jul 23 09:02:04 CST 2024, time=2024-07-23, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=1222701, encodeId=fc861222e0150, content=偏重的研究方向：生物信息 经验分享：4.16刚投了一个偏重算法的纯生信，副主编一共就请了2个审稿人，审稿人1非常nice直接同意接收，审稿人2的问题比较刁钻，尽力回复了也给拒了。副主编还会请第三位审稿人吗😔😔😔, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=233, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220527/f872d11666ad4271be846f74e02b89b7/5532cc15e85e4719abf96a130465c946.jpg, createdBy=2c908142929, createdName=ms1000001205788873, createdTime=Fri May 27 00:11:16 CST 2022, time=2022-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2116489, encodeId=b5f72116489b1, content=偏重的研究方向：肿瘤;纯生信;基因 经验分享：投了一篇转录因子调控网络图的纯生信，第一个审稿人给了2323，主要要求要我补实验，别的都是统计学小问题，准备补个PCR，希望可以过！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab055420094, createdName=少年宁, createdTime=Sun Feb 26 00:25:27 CST 2023, time=2023-02-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2203484, encodeId=0d482203484f1, content=This manuscript does not fulfill the standards established for the journal to be considered for publication, and according to Frontiers policies (https://www***ontiersin.org/guidelines/policies-and-publication-ethics#AuthorshipAuthorResponsibilities), the article is being rejected. This decision applies across all Frontiers journals and is final., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8fe96448100, createdName=ms3000000420360328, createdTime=Wed May 08 17:28:10 CST 2024, time=2024-05-08, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2145809, encodeId=544b214580929, content=审稿速度:6.0 经验分享：太无耻了，开始找的第一个审稿人建议大修，返回已经后是同意录用，后面一直在找别的审稿人，到投稿6个月的时候才找到第二个审稿人。但是奇葩操作来了，在最后一个审稿人没回复的情况下，编辑直接拒稿，我是想问这个杂志社是不是有毛病？拒稿为什么不早点拒稿，耽误别人半年时间，我想请问能不能发邮件喷这个SB编辑，再也不投这个fronter系列杂志了，白白延误别人时间又莫名其妙的拒稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=024e2688919, createdName=287119938, createdTime=Sat Jul 01 12:35:51 CST 2023, time=2023-07-01, status=1, ipAttribution=贵州省)]

2022-05-27 ms1000001205788873

偏重的研究方向：生物信息
经验分享：4.16刚投了一个偏重算法的纯生信，副主编一共就请了2个审稿人，审稿人1非常nice直接同意接收，审稿人2的问题比较刁钻，尽力回复了也给拒了。副主编还会请第三位审稿人吗😔😔😔

233 9

展开9条回复

[GetPortalCommentsPageByObjectIdResponse(id=2179183, encodeId=9b4221e9183e1, content=审稿速度:2.0 经验分享：经验分享：11月03日投稿，11月06日审稿人1 建议拒稿，11月27日审稿人2 建议Minor revision，11月28日审稿人3建议Major revision，给了2周返修时间，12月10日所有意见返修过去， 12月27日审稿人3 建议拒稿，12月28日，审稿人2 同意发表。各位帮忙分析一下我的文章还有戏吗? 焦虑中......., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=253, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=80c66157856, createdName=ms3000000029380120, createdTime=Thu Jan 04 10:11:21 CST 2024, time=2024-01-04, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1192128, encodeId=6ea2119212886, content=我的intial validation20天了。。。有没有大哥跟这个情况一样, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=22, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2fbe5639152, createdName=ms8000000759319128, createdTime=Fri Feb 11 00:09:31 CST 2022, time=2022-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2120586, encodeId=14f8212058655, content=偏重的研究方向：基因 经验分享：initial validation 3天了，一般多久啊😂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a9a48344813, createdName=ms3000001292138274, createdTime=Mon Mar 20 15:51:11 CST 2023, time=2023-03-20, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2227090, encodeId=5827222e090d9, content=我是这个杂志社的审稿人，我只要是临床工作不忙，一般都是2-3天内审完提交。因为自己经常经历漫长的投稿时间。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=283, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0ea8286723, createdName=ms3000000851999119, createdTime=Sun Sep 22 18:38:56 CST 2024, time=2024-09-22, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2221839, encodeId=9194222183913, content=偏重的研究方向：肿瘤;基因 经验分享：6月27submit 8月3日第一轮审稿意见回来，一共2个审稿人 8月14日修回 8月15日一个审稿人再次提出了一些建议，当天就修回了 8月16日和8月17日2个审稿人陆续endorse 8月21日接收整个过程挺顺利的，审稿人的审稿意见都很中肯。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a0558563830, createdName=ms1000001357370242, createdTime=Thu Aug 22 08:43:43 CST 2024, time=2024-08-22, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2216376, encodeId=039a22163e6e5, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：植物转录组 经验分享：请问大家投Frontier in genetics之前都查重了吗？杂志对重复率的要求是怎么样的呀？请前辈们都来指点迷津, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=192, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5a459395780, createdName=ms2000001592249343, createdTime=Tue Jul 23 09:02:04 CST 2024, time=2024-07-23, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=1222701, encodeId=fc861222e0150, content=偏重的研究方向：生物信息 经验分享：4.16刚投了一个偏重算法的纯生信，副主编一共就请了2个审稿人，审稿人1非常nice直接同意接收，审稿人2的问题比较刁钻，尽力回复了也给拒了。副主编还会请第三位审稿人吗😔😔😔, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=233, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220527/f872d11666ad4271be846f74e02b89b7/5532cc15e85e4719abf96a130465c946.jpg, createdBy=2c908142929, createdName=ms1000001205788873, createdTime=Fri May 27 00:11:16 CST 2022, time=2022-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2116489, encodeId=b5f72116489b1, content=偏重的研究方向：肿瘤;纯生信;基因 经验分享：投了一篇转录因子调控网络图的纯生信，第一个审稿人给了2323，主要要求要我补实验，别的都是统计学小问题，准备补个PCR，希望可以过！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab055420094, createdName=少年宁, createdTime=Sun Feb 26 00:25:27 CST 2023, time=2023-02-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2203484, encodeId=0d482203484f1, content=This manuscript does not fulfill the standards established for the journal to be considered for publication, and according to Frontiers policies (https://www***ontiersin.org/guidelines/policies-and-publication-ethics#AuthorshipAuthorResponsibilities), the article is being rejected. This decision applies across all Frontiers journals and is final., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8fe96448100, createdName=ms3000000420360328, createdTime=Wed May 08 17:28:10 CST 2024, time=2024-05-08, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2145809, encodeId=544b214580929, content=审稿速度:6.0 经验分享：太无耻了，开始找的第一个审稿人建议大修，返回已经后是同意录用，后面一直在找别的审稿人，到投稿6个月的时候才找到第二个审稿人。但是奇葩操作来了，在最后一个审稿人没回复的情况下，编辑直接拒稿，我是想问这个杂志社是不是有毛病？拒稿为什么不早点拒稿，耽误别人半年时间，我想请问能不能发邮件喷这个SB编辑，再也不投这个fronter系列杂志了，白白延误别人时间又莫名其妙的拒稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=024e2688919, createdName=287119938, createdTime=Sat Jul 01 12:35:51 CST 2023, time=2023-07-01, status=1, ipAttribution=贵州省)]

2023-02-26 少年宁来自浙江省

偏重的研究方向：肿瘤;纯生信;基因
经验分享：投了一篇转录因子调控网络图的纯生信，第一个审稿人给了2323，主要要求要我补实验，别的都是统计学小问题，准备补个PCR，希望可以过！

147 8

展开8条回复

[GetPortalCommentsPageByObjectIdResponse(id=2179183, encodeId=9b4221e9183e1, content=审稿速度:2.0 经验分享：经验分享：11月03日投稿，11月06日审稿人1 建议拒稿，11月27日审稿人2 建议Minor revision，11月28日审稿人3建议Major revision，给了2周返修时间，12月10日所有意见返修过去， 12月27日审稿人3 建议拒稿，12月28日，审稿人2 同意发表。各位帮忙分析一下我的文章还有戏吗? 焦虑中......., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=253, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=80c66157856, createdName=ms3000000029380120, createdTime=Thu Jan 04 10:11:21 CST 2024, time=2024-01-04, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1192128, encodeId=6ea2119212886, content=我的intial validation20天了。。。有没有大哥跟这个情况一样, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=22, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2fbe5639152, createdName=ms8000000759319128, createdTime=Fri Feb 11 00:09:31 CST 2022, time=2022-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2120586, encodeId=14f8212058655, content=偏重的研究方向：基因 经验分享：initial validation 3天了，一般多久啊😂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a9a48344813, createdName=ms3000001292138274, createdTime=Mon Mar 20 15:51:11 CST 2023, time=2023-03-20, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2227090, encodeId=5827222e090d9, content=我是这个杂志社的审稿人，我只要是临床工作不忙，一般都是2-3天内审完提交。因为自己经常经历漫长的投稿时间。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=283, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0ea8286723, createdName=ms3000000851999119, createdTime=Sun Sep 22 18:38:56 CST 2024, time=2024-09-22, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2221839, encodeId=9194222183913, content=偏重的研究方向：肿瘤;基因 经验分享：6月27submit 8月3日第一轮审稿意见回来，一共2个审稿人 8月14日修回 8月15日一个审稿人再次提出了一些建议，当天就修回了 8月16日和8月17日2个审稿人陆续endorse 8月21日接收整个过程挺顺利的，审稿人的审稿意见都很中肯。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a0558563830, createdName=ms1000001357370242, createdTime=Thu Aug 22 08:43:43 CST 2024, time=2024-08-22, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2216376, encodeId=039a22163e6e5, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：植物转录组 经验分享：请问大家投Frontier in genetics之前都查重了吗？杂志对重复率的要求是怎么样的呀？请前辈们都来指点迷津, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=192, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5a459395780, createdName=ms2000001592249343, createdTime=Tue Jul 23 09:02:04 CST 2024, time=2024-07-23, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=1222701, encodeId=fc861222e0150, content=偏重的研究方向：生物信息 经验分享：4.16刚投了一个偏重算法的纯生信，副主编一共就请了2个审稿人，审稿人1非常nice直接同意接收，审稿人2的问题比较刁钻，尽力回复了也给拒了。副主编还会请第三位审稿人吗😔😔😔, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=233, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220527/f872d11666ad4271be846f74e02b89b7/5532cc15e85e4719abf96a130465c946.jpg, createdBy=2c908142929, createdName=ms1000001205788873, createdTime=Fri May 27 00:11:16 CST 2022, time=2022-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2116489, encodeId=b5f72116489b1, content=偏重的研究方向：肿瘤;纯生信;基因 经验分享：投了一篇转录因子调控网络图的纯生信，第一个审稿人给了2323，主要要求要我补实验，别的都是统计学小问题，准备补个PCR，希望可以过！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab055420094, createdName=少年宁, createdTime=Sun Feb 26 00:25:27 CST 2023, time=2023-02-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2203484, encodeId=0d482203484f1, content=This manuscript does not fulfill the standards established for the journal to be considered for publication, and according to Frontiers policies (https://www***ontiersin.org/guidelines/policies-and-publication-ethics#AuthorshipAuthorResponsibilities), the article is being rejected. This decision applies across all Frontiers journals and is final., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8fe96448100, createdName=ms3000000420360328, createdTime=Wed May 08 17:28:10 CST 2024, time=2024-05-08, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2145809, encodeId=544b214580929, content=审稿速度:6.0 经验分享：太无耻了，开始找的第一个审稿人建议大修，返回已经后是同意录用，后面一直在找别的审稿人，到投稿6个月的时候才找到第二个审稿人。但是奇葩操作来了，在最后一个审稿人没回复的情况下，编辑直接拒稿，我是想问这个杂志社是不是有毛病？拒稿为什么不早点拒稿，耽误别人半年时间，我想请问能不能发邮件喷这个SB编辑，再也不投这个fronter系列杂志了，白白延误别人时间又莫名其妙的拒稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=024e2688919, createdName=287119938, createdTime=Sat Jul 01 12:35:51 CST 2023, time=2023-07-01, status=1, ipAttribution=贵州省)]

2024-05-08 ms3000000420360328 来自浙江省

This manuscript does not fulfill the standards established for the journal to be considered for publication, and according to Frontiers policies (https://www***ontiersin.org/guidelines/policies-and-publication-ethics#AuthorshipAuthorResponsibilities), the article is being rejected. This decision applies across all Frontiers journals and is final.

103 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2179183, encodeId=9b4221e9183e1, content=审稿速度:2.0 经验分享：经验分享：11月03日投稿，11月06日审稿人1 建议拒稿，11月27日审稿人2 建议Minor revision，11月28日审稿人3建议Major revision，给了2周返修时间，12月10日所有意见返修过去， 12月27日审稿人3 建议拒稿，12月28日，审稿人2 同意发表。各位帮忙分析一下我的文章还有戏吗? 焦虑中......., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=253, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=80c66157856, createdName=ms3000000029380120, createdTime=Thu Jan 04 10:11:21 CST 2024, time=2024-01-04, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1192128, encodeId=6ea2119212886, content=我的intial validation20天了。。。有没有大哥跟这个情况一样, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=22, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=2fbe5639152, createdName=ms8000000759319128, createdTime=Fri Feb 11 00:09:31 CST 2022, time=2022-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2120586, encodeId=14f8212058655, content=偏重的研究方向：基因 经验分享：initial validation 3天了，一般多久啊😂, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a9a48344813, createdName=ms3000001292138274, createdTime=Mon Mar 20 15:51:11 CST 2023, time=2023-03-20, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2227090, encodeId=5827222e090d9, content=我是这个杂志社的审稿人，我只要是临床工作不忙，一般都是2-3天内审完提交。因为自己经常经历漫长的投稿时间。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=283, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0ea8286723, createdName=ms3000000851999119, createdTime=Sun Sep 22 18:38:56 CST 2024, time=2024-09-22, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2221839, encodeId=9194222183913, content=偏重的研究方向：肿瘤;基因 经验分享：6月27submit 8月3日第一轮审稿意见回来，一共2个审稿人 8月14日修回 8月15日一个审稿人再次提出了一些建议，当天就修回了 8月16日和8月17日2个审稿人陆续endorse 8月21日接收整个过程挺顺利的，审稿人的审稿意见都很中肯。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a0558563830, createdName=ms1000001357370242, createdTime=Thu Aug 22 08:43:43 CST 2024, time=2024-08-22, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2216376, encodeId=039a22163e6e5, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：植物转录组 经验分享：请问大家投Frontier in genetics之前都查重了吗？杂志对重复率的要求是怎么样的呀？请前辈们都来指点迷津, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=192, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5a459395780, createdName=ms2000001592249343, createdTime=Tue Jul 23 09:02:04 CST 2024, time=2024-07-23, status=1, ipAttribution=甘肃省), GetPortalCommentsPageByObjectIdResponse(id=1222701, encodeId=fc861222e0150, content=偏重的研究方向：生物信息 经验分享：4.16刚投了一个偏重算法的纯生信，副主编一共就请了2个审稿人，审稿人1非常nice直接同意接收，审稿人2的问题比较刁钻，尽力回复了也给拒了。副主编还会请第三位审稿人吗😔😔😔, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=233, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220527/f872d11666ad4271be846f74e02b89b7/5532cc15e85e4719abf96a130465c946.jpg, createdBy=2c908142929, createdName=ms1000001205788873, createdTime=Fri May 27 00:11:16 CST 2022, time=2022-05-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2116489, encodeId=b5f72116489b1, content=偏重的研究方向：肿瘤;纯生信;基因 经验分享：投了一篇转录因子调控网络图的纯生信，第一个审稿人给了2323，主要要求要我补实验，别的都是统计学小问题，准备补个PCR，希望可以过！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ab055420094, createdName=少年宁, createdTime=Sun Feb 26 00:25:27 CST 2023, time=2023-02-26, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2203484, encodeId=0d482203484f1, content=This manuscript does not fulfill the standards established for the journal to be considered for publication, and according to Frontiers policies (https://www***ontiersin.org/guidelines/policies-and-publication-ethics#AuthorshipAuthorResponsibilities), the article is being rejected. This decision applies across all Frontiers journals and is final., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8fe96448100, createdName=ms3000000420360328, createdTime=Wed May 08 17:28:10 CST 2024, time=2024-05-08, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2145809, encodeId=544b214580929, content=审稿速度:6.0 经验分享：太无耻了，开始找的第一个审稿人建议大修，返回已经后是同意录用，后面一直在找别的审稿人，到投稿6个月的时候才找到第二个审稿人。但是奇葩操作来了，在最后一个审稿人没回复的情况下，编辑直接拒稿，我是想问这个杂志社是不是有毛病？拒稿为什么不早点拒稿，耽误别人半年时间，我想请问能不能发邮件喷这个SB编辑，再也不投这个fronter系列杂志了，白白延误别人时间又莫名其妙的拒稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=159, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=024e2688919, createdName=287119938, createdTime=Sat Jul 01 12:35:51 CST 2023, time=2023-07-01, status=1, ipAttribution=贵州省)]

2023-07-01 287119938 来自贵州省

审稿速度:6.0
经验分享：太无耻了，开始找的第一个审稿人建议大修，返回已经后是同意录用，后面一直在找别的审稿人，到投稿6个月的时候才找到第二个审稿人。但是奇葩操作来了，在最后一个审稿人没回复的情况下，编辑直接拒稿，我是想问这个杂志社是不是有毛病？拒稿为什么不早点拒稿，耽误别人半年时间，我想请问能不能发邮件喷这个SB编辑，再也不投这个fronter系列杂志了，白白延误别人时间又莫名其妙的拒稿。

159 3

展开3条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务